{
  "pmid": "35234610",
  "uid": "35234610",
  "title": "NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats.",
  "abstract": "NBI-921352 (formerly XEN901) is a novel sodium channel inhibitor designed to specifically target NaV1.6 channels. Such a molecule provides a precision-medicine approach to target SCN8A-related epilepsy syndromes (SCN8A-RES), where gain-of-function (GoF) mutations lead to excess NaV1.6 sodium current, or other indications where NaV1.6 mediated hyper-excitability contributes to disease (Gardella and Møller, 2019; Johannesen et al., 2019; Veeramah et al., 2012). NBI-921352 is a potent inhibitor of NaV1.6 (IC500.051 µM), with exquisite selectivity over other sodium channel isoforms (selectivity ratios of 756 X for NaV1.1, 134 X for NaV1.2, 276 X for NaV1.7, and >583 Xfor NaV1.3, NaV1.4, and NaV1.5). NBI-921352is a state-dependent inhibitor, preferentially inhibiting inactivatedchannels. The state dependence leads to potent stabilization of inactivation, inhibiting NaV1.6 currents, including resurgent and persistent NaV1.6 currents, while sparing the closed/rested channels. The isoform-selective profile of NBI-921352 led to a robust inhibition of action-potential firing in glutamatergic excitatory pyramidal neurons, while sparing fast-spiking inhibitory interneurons, where NaV1.1 predominates. Oral administration of NBI-921352 prevented electrically induced seizures in a Scn8a GoF mouse,as well as in wild-type mouse and ratseizure models. NBI-921352 was effective in preventing seizures at lower brain and plasma concentrations than commonly prescribed sodium channel inhibitor anti-seizure medicines (ASMs) carbamazepine, phenytoin, and lacosamide. NBI-921352 waswell tolerated at higher multiples of the effective plasma and brain concentrations than those ASMs. NBI-921352 is entering phase II proof-of-concept trials for the treatment of SCN8A-developmental epileptic encephalopathy (SCN8A-DEE) and adult focal-onset seizures.",
  "authors": [
    {
      "last_name": "Johnson",
      "fore_name": "J P",
      "initials": "JP",
      "name": "J P Johnson",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ],
      "orcid": "0000-0002-5762-5138"
    },
    {
      "last_name": "Focken",
      "fore_name": "Thilo",
      "initials": "T",
      "name": "Thilo Focken",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Khakh",
      "fore_name": "Kuldip",
      "initials": "K",
      "name": "Kuldip Khakh",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Tari",
      "fore_name": "Parisa Karimi",
      "initials": "PK",
      "name": "Parisa Karimi Tari",
      "affiliations": [
        "In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Dube",
      "fore_name": "Celine",
      "initials": "C",
      "name": "Celine Dube",
      "affiliations": [
        "In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Goodchild",
      "fore_name": "Samuel J",
      "initials": "SJ",
      "name": "Samuel J Goodchild",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Andrez",
      "fore_name": "Jean-Christophe",
      "initials": "JC",
      "name": "Jean-Christophe Andrez",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Bankar",
      "fore_name": "Girish",
      "initials": "G",
      "name": "Girish Bankar",
      "affiliations": [
        "In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Bogucki",
      "fore_name": "David",
      "initials": "D",
      "name": "David Bogucki",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada.",
        "Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada."
      ]
    },
    {
      "last_name": "Burford",
      "fore_name": "Kristen",
      "initials": "K",
      "name": "Kristen Burford",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Chang",
      "fore_name": "Elaine",
      "initials": "E",
      "name": "Elaine Chang",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Chowdhury",
      "fore_name": "Sultan",
      "initials": "S",
      "name": "Sultan Chowdhury",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Dean",
      "fore_name": "Richard",
      "initials": "R",
      "name": "Richard Dean",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "de Boer",
      "fore_name": "Gina",
      "initials": "G",
      "name": "Gina de Boer",
      "affiliations": [
        "Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada."
      ]
    },
    {
      "last_name": "Decker",
      "fore_name": "Shannon",
      "initials": "S",
      "name": "Shannon Decker",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Dehnhardt",
      "fore_name": "Christoph",
      "initials": "C",
      "name": "Christoph Dehnhardt",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Feng",
      "fore_name": "Mandy",
      "initials": "M",
      "name": "Mandy Feng",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Gong",
      "fore_name": "Wei",
      "initials": "W",
      "name": "Wei Gong",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Grimwood",
      "fore_name": "Michael",
      "initials": "M",
      "name": "Michael Grimwood",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Hasan",
      "fore_name": "Abid",
      "initials": "A",
      "name": "Abid Hasan",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Hussainkhel",
      "fore_name": "Angela",
      "initials": "A",
      "name": "Angela Hussainkhel",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Jia",
      "fore_name": "Qi",
      "initials": "Q",
      "name": "Qi Jia",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Lee",
      "fore_name": "Stephanie",
      "initials": "S",
      "name": "Stephanie Lee",
      "affiliations": [
        "Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada."
      ]
    },
    {
      "last_name": "Li",
      "fore_name": "Jenny",
      "initials": "J",
      "name": "Jenny Li",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Lin",
      "fore_name": "Sophia",
      "initials": "S",
      "name": "Sophia Lin",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Lindgren",
      "fore_name": "Andrea",
      "initials": "A",
      "name": "Andrea Lindgren",
      "affiliations": [
        "Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada."
      ]
    },
    {
      "last_name": "Lofstrand",
      "fore_name": "Verner",
      "initials": "V",
      "name": "Verner Lofstrand",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Mezeyova",
      "fore_name": "Janette",
      "initials": "J",
      "name": "Janette Mezeyova",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Namdari",
      "fore_name": "Rostam",
      "initials": "R",
      "name": "Rostam Namdari",
      "affiliations": [
        "Translational Drug Development, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Nelkenbrecher",
      "fore_name": "Karen",
      "initials": "K",
      "name": "Karen Nelkenbrecher",
      "affiliations": [
        "In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Shuart",
      "fore_name": "Noah Gregory",
      "initials": "NG",
      "name": "Noah Gregory Shuart",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Sojo",
      "fore_name": "Luis",
      "initials": "L",
      "name": "Luis Sojo",
      "affiliations": [
        "Compound Properties, Xenon Pharmaceuticals Inc, Burnaby BC, Canada."
      ]
    },
    {
      "last_name": "Sun",
      "fore_name": "Shaoyi",
      "initials": "S",
      "name": "Shaoyi Sun",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Taron",
      "fore_name": "Matthew",
      "initials": "M",
      "name": "Matthew Taron",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Waldbrook",
      "fore_name": "Matthew",
      "initials": "M",
      "name": "Matthew Waldbrook",
      "affiliations": [
        "In Vivo Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Weeratunge",
      "fore_name": "Diana",
      "initials": "D",
      "name": "Diana Weeratunge",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Wesolowski",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Wesolowski",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Williams",
      "fore_name": "Aaron",
      "initials": "A",
      "name": "Aaron Williams",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Wilson",
      "fore_name": "Michael",
      "initials": "M",
      "name": "Michael Wilson",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Xie",
      "fore_name": "Zhiwei",
      "initials": "Z",
      "name": "Zhiwei Xie",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Yoo",
      "fore_name": "Rhena",
      "initials": "R",
      "name": "Rhena Yoo",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Young",
      "fore_name": "Clint",
      "initials": "C",
      "name": "Clint Young",
      "affiliations": [
        "In Vitro Biology, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Zenova",
      "fore_name": "Alla",
      "initials": "A",
      "name": "Alla Zenova",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Zhang",
      "fore_name": "Wei",
      "initials": "W",
      "name": "Wei Zhang",
      "affiliations": [
        "Chemistry, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Cutts",
      "fore_name": "Alison J",
      "initials": "AJ",
      "name": "Alison J Cutts",
      "affiliations": [
        "Scientific Affairs, Xenon Pharmaceuticals, Inc, Burnaby BC, Canada."
      ],
      "orcid": "0000-0002-4986-573X"
    },
    {
      "last_name": "Sherrington",
      "fore_name": "Robin P",
      "initials": "RP",
      "name": "Robin P Sherrington",
      "affiliations": [
        "Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Pimstone",
      "fore_name": "Simon N",
      "initials": "SN",
      "name": "Simon N Pimstone",
      "affiliations": [
        "Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Winquist",
      "fore_name": "Raymond",
      "initials": "R",
      "name": "Raymond Winquist",
      "affiliations": [
        "Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Cohen",
      "fore_name": "Charles J",
      "initials": "CJ",
      "name": "Charles J Cohen",
      "affiliations": [
        "Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    },
    {
      "last_name": "Empfield",
      "fore_name": "James R",
      "initials": "JR",
      "name": "James R Empfield",
      "affiliations": [
        "Executive Team, Xenon Pharmaceuticals Inc, Burnaby, Canada."
      ]
    }
  ],
  "journal": {
    "title": "eLife",
    "iso_abbreviation": "Elife",
    "issn": "2050-084X",
    "issn_type": "Electronic",
    "volume": "11",
    "pub_year": "2022",
    "pub_month": "Mar",
    "pub_day": "02"
  },
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Animals",
    "Epilepsy",
    "Gain of Function Mutation",
    "Mice",
    "Mutation",
    "NAV1.6 Voltage-Gated Sodium Channel",
    "Neurons",
    "Rats",
    "Sodium",
    "Sodium Channel Blockers"
  ],
  "article_ids": {
    "pubmed": "35234610",
    "pmc": "PMC8903829",
    "doi": "10.7554/eLife.72468",
    "pii": "72468"
  },
  "doi": "10.7554/eLife.72468",
  "pmc_id": "PMC8903829",
  "dates": {
    "completed": "2022-04-29",
    "revised": "2022-04-29"
  },
  "chemicals": [
    "NAV1.6 Voltage-Gated Sodium Channel",
    "Scn8a protein, mouse",
    "Sodium Channel Blockers",
    "Sodium"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:10:00.743926",
    "pmid": "35234610"
  }
}